COVID-19 rebound after Paxlovid treatment likely due to insufficient exposure to the drug
June 21, 2022 at 19:59 PM EDT
A CDC study of the COVID-19 treatment drug, Paxlovid shows that instances of symptom rebound after treatment may be due to under exposure to the drug